Device Trial Radar · NCT07909486
Identification of Biomarkers for Vagus Nerve Stimulation in Patients With Refractory Epilepsy
Last checked: Nov 19, 2026Latest source record: Nov 5, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
20
Planned (sponsor's estimate)
Start
Feb 28, 2022
Primary completion
Sep 1, 2025
Study completion Dec 2028
Sponsor
- Lead sponsor
- Cliniques universitaires Saint-Luc- Université Catholique de LouvainAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Nov 2, 2026
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Other
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years, up to 79 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
A VNS longitudinal study focused on pre and post-VNS implantation in order to predict the VNS response and to understand better mechanisms of VNS using some connectivity and network measures.
Conditions
- Refractory Epilepsy
Interventions
Vagus nerve stimulationDevice
No intervention was performed for the study, since VNS is already part of the treatment of these patients. However, VNS parameters are changed for the sake of the study and reestablished at the end.
Primary outcomes
What the sponsor says the trial is designed to measure.
- PupillometryTime frame: Before Implantation, 3 Months, and 6 Months Post Implantation
- P300Time frame: Before Implantation, 3 Months, and 6 Months Post Implantation
- LMEPTime frame: Before Implantation, 3 Months, and 6 Months Post Implantation
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Clinique Universitaires Saint-Luc
Brussels, Belgium · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.